Production, Quality Control, Stability and Pharmacotoxicity of a Malaria Vaccine Comprising Three Highly Similar PfAMA1 Protein Molecules to Overcome Antigenic Variation

• Bart W. Faber ,

  Contributed equally to this work with: Bart W. Faber, Stephan Hellwig

  * E-mail: Faber@bprc.nl

  Affiliation Department of Parasitology, Biomedical Primate Research Centre, Rijswijk, The Netherlands

  http://orcid.org/0000-0001-6808-1204

  ⨯
• Stephan Hellwig ,

  Contributed equally to this work with: Bart W. Faber, Stephan Hellwig

  Affiliation Fraunhofer IME, Aachen, Germany

  ⨯
• Sophie Houard,

  Affiliation European Vaccine Initiative, Universitätsklinikum Heidelberg, Heidelberg, Germany

  ⨯
• Nicolas Havelange,

  Affiliation European Vaccine Initiative, Universitätsklinikum Heidelberg, Heidelberg, Germany

  ⨯
• Jürgen Drossard,

  Affiliation Fraunhofer IME, Aachen, Germany

  ⨯
• Hubert Mertens,

  Affiliation Fraunhofer IME, Aachen, Germany

  ⨯
• Alexander Croon,

  Affiliation Fraunhofer IME, Aachen, Germany

  ⨯
• Robin Kastilan,

  Affiliation Fraunhofer IME, Aachen, Germany

  ⨯
• Richard Byrne,

  Affiliation Nova Laboratories Ltd., Martin House, Gloucester Crescent, Wigston, Leicester, United Kingdom

  ⨯
• Nicole van der Werff,

  Affiliation Department of Parasitology, Biomedical Primate Research Centre, Rijswijk, The Netherlands

  ⨯
• Marjolein van der Eijk,

  Affiliation Department of Parasitology, Biomedical Primate Research Centre, Rijswijk, The Netherlands

  ⨯
• Alan W. Thomas,

  Affiliation Department of Parasitology, Biomedical Primate Research Centre, Rijswijk, The Netherlands

  ⨯
• Clemens H. M. Kocken,

  Affiliation Department of Parasitology, Biomedical Primate Research Centre, Rijswijk, The Netherlands

  ⨯
• Edmond J. Remarque

  Affiliation Department of Parasitology, Biomedical Primate Research Centre, Rijswijk, The Netherlands

  ⨯